Cargando…

Blood-Based Biomarkers for COVID-19-Associated Neurological Outcomes

Detalles Bibliográficos
Autor principal:	De Felice, Fernanda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046773/ http://dx.doi.org/10.1016/j.biopsych.2022.02.089

Ejemplares similares

Long-term neurologic outcomes of COVID-19
por: Xu, Evan, et al.
Publicado: (2022)

Neurological associations of COVID-19
por: Ellul, Mark A, et al.
Publicado: (2020)

Blood Biomarkers as Prognostic Indicators for Neurological Injury in COVID-19 Patients: A Systematic Review and Meta-Analysis
por: Huang, Zhiwei, et al.
Publicado: (2023)

Plasma biomarkers of brain injury in COVID-19 patients with neurological symptoms
por: Sahin, B.E., et al.
Publicado: (2022)

Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations
por: Sun, Bing, et al.
Publicado: (2021)

Blood Biomarkers from the Emergency Department Disclose Severe Omicron COVID-19-Associated Outcomes
por: Pennacchia, Fiorenza, et al.
Publicado: (2023)

The blood-brain barrier in health, neurological diseases, and COVID-19
por: Chen, Jianan, et al.
Publicado: (2022)

Quantification of Neurological Blood-Based Biomarkers in Critically Ill Patients With Coronavirus Disease 2019
por: Cooper, Jennifer, et al.
Publicado: (2020)

Neurological dysfunction associated with COVID-19
por: da Silva, Filipa Sofia Camacho Alves, et al.
Publicado: (2021)

COVID-19 Associated Neurological Manifestations
por: Kulkarni, Rahul, et al.
Publicado: (2021)

COVID-19 Associated Neurological Manifestation
por: Mubaraki, Adnan A, et al.
Publicado: (2023)

Blood biomarkers for HIV infection with focus on neurologic complications—A review
por: Hagberg, Lars, et al.
Publicado: (2022)

Delays in thrombolysis during COVID-19 are associated with worse neurological outcomes: the Society of Vascular and Interventional Neurology Multicenter Collaboration
por: Jillella, Dinesh V., et al.
Publicado: (2021)

Neurological manifestations associated with COVID-19 vaccine
por: Alonso Castillo, R., et al.
Publicado: (2022)

COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders
por: Conway, Sarah E., et al.
Publicado: (2022)

Spectrum, risk factors and outcomes of neurological complications of COVID-19
por: Russell, Amy Ross, et al.
Publicado: (2021)

COVID-19-associated encephalopathy: Neurological manifestation of COVID-19
por: Al Mazrouei, Safaa Saeed, et al.
Publicado: (2020)

Environmental Issues and Neurological Manifestations Associated with COVID-19 Pandemic: New Aspects of the Disease?
por: Bellocchio, Luigi, et al.
Publicado: (2020)

Neurological and psychiatric presentations associated with COVID-19
por: He, Xudong, et al.
Publicado: (2021)

Biomarkers of Neurological Damage: From Acute Stage to Post-Acute Sequelae of COVID-19
por: Zingaropoli, Maria Antonella, et al.
Publicado: (2023)

Neurology of COVID-19 in Singapore
por: Koh, Jasmine Shimin, et al.
Publicado: (2020)

Comorbidities, sequelae, blood biomarkers and their associated clinical outcomes in the Mount Sinai Health System COVID-19 patients
por: Brojakowska, Agnieszka, et al.
Publicado: (2021)

No evidence of adverse neurological outcomes from COVID-19 vaccines
Publicado: (2022)

Neurological Predictors of Clinical Outcomes in Hospitalized Patients With COVID-19
por: Salahuddin, Hisham, et al.
Publicado: (2020)

Altered pulmonary blood volume distribution as a biomarker for predicting outcomes in COVID-19 disease
por: Morris, Michael F., et al.
Publicado: (2021)

Editorial: Biomarkers in Neurology
por: Mondello, Stefania, et al.
Publicado: (2020)

The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19
por: Hogberg, Helena T., et al.
Publicado: (2022)

COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Barrier Relevance
por: Achar, Aneesha, et al.
Publicado: (2020)

Amyloid processing in COVID‐19‐associated neurological syndromes
por: Ziff, Oliver J., et al.
Publicado: (2022)

Chronic neurological diseases and COVID-19: Associations and considerations
por: Meshkat, Shakila, et al.
Publicado: (2020)

Prevalence of neurological manifestations in COVID-19 and their association with mortality
por: Carlos, C.R., et al.
Publicado: (2021)

Mild COVID-19 infection associates with persistent neurological symptoms
por: Scardua Silva, Lucas, et al.
Publicado: (2021)

Neurological and neuropsychiatric disorders associated with COVID-19. Part I: overview and neurological disorders
por: Giacalone, Martina, et al.
Publicado: (2021)

Neurologic manifestations associated with COVID-19: a multicentre registry
por: Meppiel, Elodie, et al.
Publicado: (2021)

Neurologic complications of COVID-19
por: Bridwell, Rachel, et al.
Publicado: (2020)

The neurologic complications of COVID-19
por: Roman, Gustavo
Publicado: (2021)

COVID-19: Neurologic complications and management of neurological symptoms
por: Jupe, T., et al.
Publicado: (2023)

Increased Blood Pressure Variability Is Associated with Worse Neurologic Outcome in Acute Anterior Circulation Ischemic Stroke
por: de Havenon, Adam, et al.
Publicado: (2016)

Prognostic peripheral blood biomarkers at ICU admission predict COVID-19 clinical outcomes
por: Messing, Melina, et al.
Publicado: (2022)

Post COVID-19 Vaccination-Associated Neurological Complications
por: Assiri, Sara A, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_80iec4amn5s5lvfdkvcfjnc98i